Articles & Stories | Optimal340B

340B In the Know

Finding it hard to stay updated on the latest 340B Drug Pricing Program changes and trends?

We've got you covered.

Lyssa Limbrecht

Undermining the 340B Program: AHA Express' Concern about Drug Companies' Actions

The American Hospital Association (AHA) has just released letters to five leading U.S drug companies. Turns out, these companies may have be

Lyssa Limbrecht

Improve Compliance and Create Transparency with 340B Rebates

In a recent post by Adam J. Fein, CEO of Drug Channels Institute, he shares insight on why the 340B Drug Pricing Program needs to become a "

Lyssa Limbrecht

Omnicell Buys PSG’s 340B Line of Business, the Latest in a Trend of 340B TPA

Omnicell is already a leading provider of prescription drug chain products and services. Now, they've purchased PSG's 340B line of business